Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Alkermes Announces FDA Grants Orphan Drug Designation For Nemvaleukin Alfa For Treatment Of Mucosal Melanoma


RTTNews | Mar 11, 2021 07:02AM EST

07:01 Thursday, March 11, 2021 (RTTNews) - Alkermes Announces FDA Grants Orphan Drug Designation For Nemvaleukin Alfa For Treatment Of Mucosal Melanoma

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC